Welcome of Almac Announcement on Cancer Research Success
Enterprise, Trade and Investment Minister Arlene Foster has welcomed the announcement by Almac Diagnostics that their research has resulted in information that will significantly benefit the treatment of ovarian cancer patients.
The company’s ground-breaking £8million research project studied molecular subgroups in various cancers. Invest NI provided £2.75million of support to the R&D project, part funded by the European Regional Development Fund.
Welcoming the announcement made at the American Society of Clinical Oncology in Chicago, Arlene Foster said: “The Almac Group has been at the forefront of the global pharmaceutical and biotechnology sectors for many years. Its research has resulted in a number of breakthrough developments and this latest achievement elevates the company further within the precision medicine arena.
“The Northern Ireland Executive through its departments and Invest Northern Ireland has supported the development of a strong and internationally recognised Life Sciences sector here. The sector includes a number of world-leading companies such as Almac and Randox as well as our world-class academic research centres.
“I congratulate Almac on the success of this research project. The benefits will include not only improvements in personalised cancer treatment but also significant savings to healthcare organisations around the world.”